SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-22-005749
Filing Date
2022-08-09
Accepted
2022-08-09 13:51:39
Documents
55
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nbio_10q.htm   iXBRL 10-Q 464690
2 CERTIFICATION nbio_ex311.htm EX-31.1 9541
3 CERTIFICATION nbio_ex312.htm EX-31.2 9715
4 CERTIFICATION nbio_ex321.htm EX-32.1 3759
5 CERTIFICATION nbio_ex322.htm EX-32.2 3780
  Complete submission text file 0001477932-22-005749.txt   2767214

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nbio-20220630.xsd EX-101.SCH 43864
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20220630_lab.xml EX-101.LAB 224656
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20220630_cal.xml EX-101.CAL 33377
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20220630_pre.xml EX-101.PRE 179925
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20220630_def.xml EX-101.DEF 79228
49 EXTRACTED XBRL INSTANCE DOCUMENT nbio_10q_htm.xml XML 320900
Mailing Address 623 17TH STREET, SUITE 4 VERO BEACH FL 32960
Business Address 623 17TH STREET, SUITE 4 VERO BEACH FL 32960 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

IRS No.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55299 | Film No.: 221147501
SIC: 2834 Pharmaceutical Preparations